Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E19.66 EPS (ttm)12.24 Insider Own0.20% Shs Outstand588.00M Perf Week-1.63%
Market Cap141.82B Forward P/E14.27 EPS next Y16.86 Insider Trans-0.41% Shs Float580.14M Perf Month-4.36%
Income7.30B PEG2.67 EPS next Q3.80 Inst Own78.60% Short Float0.95% Perf Quarter2.50%
Sales24.30B P/S5.84 EPS this Y2.00% Inst Trans0.30% Short Ratio2.09 Perf Half Y4.95%
Book/sh18.13 P/B13.28 EPS next Y7.04% ROA11.90% Target Price262.76 Perf Year29.94%
Cash/sh19.38 P/C12.42 EPS next 5Y7.36% ROE71.70% 52W Range177.05 - 264.97 Perf YTD-0.16%
Dividend6.40 P/FCF21.51 EPS past 5Y14.00% ROI21.20% 52W High-9.16% Beta0.93
Dividend %2.66% Quick Ratio1.80 Sales past 5Y3.10% Gross Margin78.20% 52W Low35.94% ATR6.29
Employees23400 Current Ratio2.20 Sales Q/Q5.70% Oper. Margin37.90% RSI (14)42.75 Volatility1.83% 2.23%
OptionableYes Debt/Eq3.21 EPS Q/Q-14.70% Profit Margin30.00% Rel Volume0.51 Prev Close241.55
ShortableYes LT Debt/Eq3.20 EarningsJul 28 AMC Payout49.50% Avg Volume2.63M Price240.69
Recom2.20 SMA20-4.06% SMA500.21% SMA2005.59% Volume1,346,540 Change-0.36%
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Aug-06-20 04:10PM  
Aug-04-20 08:29AM  
Aug-03-20 07:56AM  
07:30AM  
07:00AM  
05:45AM  
Jul-30-20 10:24AM  
07:59AM  
06:27AM  
06:19AM  
Jul-29-20 12:25PM  
11:03AM  
10:14AM  
Jul-28-20 09:30PM  
08:49PM  
05:25PM  
05:18PM  
04:51PM  
04:25PM  
04:03PM  
08:19AM  
Jul-27-20 12:05PM  
Jul-26-20 12:34PM  
Jul-24-20 08:07PM  
11:13AM  
Jul-23-20 05:05PM  
05:00PM  
04:15PM  
04:00PM  
03:55PM  
Jul-21-20 12:31PM  
09:00AM  
09:00AM  
07:01AM  
Jul-16-20 06:22PM  
10:31AM  
09:27AM  
Jul-15-20 03:35PM  
03:29PM  
Jul-13-20 10:51AM  
10:11AM  
06:40AM  
Jul-12-20 10:00PM  
Jul-09-20 07:34AM  
Jul-08-20 10:22AM  
Jul-07-20 05:02PM  
03:42PM  
02:41PM  
10:00AM  
08:17AM  
Jul-06-20 10:11AM  
07:00AM  
Jul-02-20 01:35PM  
11:00AM  
09:03AM  
08:55AM  
Jul-01-20 07:28PM  
04:25PM  
03:47PM  
03:30PM  
02:51PM  
02:35PM  
01:35PM  
01:28PM  
12:28PM  
11:50AM  
10:42AM  
Jun-29-20 06:57PM  
Jun-26-20 09:41AM  
Jun-24-20 02:00PM  
11:00AM  
11:00AM  
Jun-23-20 12:09PM  
Jun-22-20 05:17PM  
04:00PM  
11:30AM  
Jun-19-20 12:00PM  
Jun-18-20 04:00PM  
Jun-16-20 01:05PM  
Jun-15-20 09:36AM  
09:24AM  
Jun-14-20 11:16AM  
Jun-12-20 07:06PM  
11:16AM  
Jun-11-20 11:30AM  
Jun-08-20 02:48PM  
07:55AM  
Jun-05-20 04:00PM  
Jun-04-20 08:14AM  
Jun-03-20 11:38AM  
Jun-02-20 06:00AM  
Jun-01-20 09:53AM  
08:00AM  
07:47AM  
May-30-20 11:31AM  
May-29-20 07:38PM  
04:32PM  
12:39PM  
08:00AM  
May-28-20 05:25PM  
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorJul 22Option Exercise54.691,00054,69016,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJul 22Sale259.791,000259,79015,589Jul 22 06:11 PM
SUGAR RONALD DDirectorJun 17Option Exercise54.691,00054,69016,576Jun 17 06:11 PM
SUGAR RONALD DDirectorJun 17Sale228.541,000228,54015,576Jun 17 06:11 PM
SUGAR RONALD DDirectorMay 20Option Exercise54.691,00054,69016,482May 20 09:24 PM
SUGAR RONALD DDirectorMay 20Sale229.271,000229,27015,482May 20 09:24 PM
Williams R SandersDirectorMay 06Sale237.31425100,8575,409May 07 08:49 PM
SUGAR RONALD DDirectorApr 22Option Exercise54.691,00054,69015,636Apr 22 07:07 PM
SUGAR RONALD DDirectorApr 22Sale233.351,000233,35014,636Apr 22 07:07 PM
Bradway Robert AChairman, CEO and PresidentApr 13Option Exercise58.43127,0007,420,610595,516Apr 13 07:54 PM
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM